These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30082281)

  • 21. Emergence of the novel sixth
    Khan T; Faysal NI; Hossain MM; Mah-E-Muneer S; Haider A; Moon SB; Sen D; Ahmed D; Parnell LA; Jubair M; Chow NA; Chowdhury F; Rahman M
    Microbiol Spectr; 2024 Jul; 12(7):e0354023. PubMed ID: 38842332
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Nobrega de Almeida J; Jimenez-Ortigosa C; Francisco EC; Colombo AL; Perlin DS
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0110122. PubMed ID: 36374073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
    Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species.
    Silva DB; Rodrigues LM; Almeida AA; Oliveira KM; Grisolia AB
    Mem Inst Oswaldo Cruz; 2016 Mar; 111(3):192-9. PubMed ID: 26982177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of Candida auris outbreak isolates in Qatar from patients with COVID-19 reveals the emergence of isolates resistant to three classes of antifungal drugs.
    Ben Abid F; Salah H; Sundararaju S; Dalil L; Abdelwahab AH; Salameh S; Ibrahim EB; Almaslmani MA; Tang P; Perez-Lopez A; Tsui CKM
    Clin Microbiol Infect; 2023 Aug; 29(8):1083.e1-1083.e7. PubMed ID: 37116861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.
    Strzelczyk JK; Slemp-Migiel A; Rother M; Gołąbek K; Wiczkowski A
    Acta Biochim Pol; 2013; 60(4):547-52. PubMed ID: 24340302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic Analysis of
    Kim SH; Iyer KR; Pardeshi L; Muñoz JF; Robbins N; Cuomo CA; Wong KH; Cowen LE
    mBio; 2019 Jan; 10(1):. PubMed ID: 30696744
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
    Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First detection of mutated ERG11 gene in vulvovaginal Candida albicans isolates at Ouagadougou/Burkina Faso.
    Dovo EE; Zohoncon TM; Tovo SF; Soubeiga ST; Kiendrebeogo IT; Yonli AT; Ouedraogo RA; Dabire AM; Djigma FW; Nadembega CW; Belemgnegre M; Ouedraogo P; Obiri-Yeboah D; Simpore J
    BMC Infect Dis; 2022 Aug; 22(1):678. PubMed ID: 35941587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
    Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
    Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: Possible effective substitutions and homology modelling.
    Nabili M; Abdollahi Gohar A; Badali H; Mohammadi R; Moazeni M
    J Glob Antimicrob Resist; 2016 Jun; 5():42-6. PubMed ID: 27436465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China.
    Ge SH; Wan Z; Li J; Xu J; Li RY; Bai FY
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3126-31. PubMed ID: 20516286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.
    Lockhart SR; Etienne KA; Vallabhaneni S; Farooqi J; Chowdhary A; Govender NP; Colombo AL; Calvo B; Cuomo CA; Desjardins CA; Berkow EL; Castanheira M; Magobo RE; Jabeen K; Asghar RJ; Meis JF; Jackson B; Chiller T; Litvintseva AP
    Clin Infect Dis; 2017 Jan; 64(2):134-140. PubMed ID: 27988485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.
    Flowers SA; Colón B; Whaley SG; Schuler MA; Rogers PD
    Antimicrob Agents Chemother; 2015 Jan; 59(1):450-60. PubMed ID: 25385095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.
    Wang H; Kong F; Sorrell TC; Wang B; McNicholas P; Pantarat N; Ellis D; Xiao M; Widmer F; Chen SC
    BMC Microbiol; 2009 Aug; 9():167. PubMed ID: 19682357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of ERG11 Overexpression in Candida albicans isolates from environmental sources and clinical isolates treated with inhibitory and subinhibitory concentrations of fluconazole.
    Morais Vasconcelos Oliveira J; Conceição Oliver J; Latércia Tranches Dias A; Barbosa Padovan AC; Siqueira Caixeta E; Caixeta Franco Ariosa M
    Mycoses; 2021 Feb; 64(2):220-227. PubMed ID: 33176021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azole-Resistant Alleles of
    Vu BG; Moye-Rowley WS
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0209821. PubMed ID: 35007132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in
    Rybak JM; Muñoz JF; Barker KS; Parker JE; Esquivel BD; Berkow EL; Lockhart SR; Gade L; Palmer GE; White TC; Kelly SL; Cuomo CA; Rogers PD
    mBio; 2020 May; 11(3):. PubMed ID: 32398311
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.